Financhill
Back

Range Cancer Therapeutics ETF Vs. Strategy Industry Stock Comparison

Sell
12

CNCR
Range Cancer Therapeutics ETF

Last Price:
$11.00
Seasonality Move:
-3.32%
Sell
35

MSTR
Strategy

Last Price:
$262.56
Seasonality Move:
-7.07%
Sell
12
Range Cancer Therapeutics ETF (CNCR) is a Sell

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $10.93. The Score for CNCR is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
Strategy (MSTR) is a Sell

Is Strategy a Buy, Sell or Hold?

  • The current Strategy [MSTR] share price is $262.55. The Score for MSTR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • MSTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $10.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing slight buying pressure.

MSTR Stock Price Chart

What is Strategy's stock price today?

  • The Strategy share price today is $262.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSTR is experiencing slight buying pressure.

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 38.23 Sell
Chaikin Money Flow: 171 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

MSTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -17.11 Sell
Relative Strength Index (14 RSI): 42.7 Sell
Chaikin Money Flow: 4725568 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11 Sell
20-day SMA: 11.72 Sell
50-day SMA: 12.06 Sell
200-day SMA: 13.89 Sell
8-day EMA: 11.1 Sell
20-day EMA: 11.52 Sell
50-day EMA: 12.12 Sell
200-day EMA: 13.43 Sell

MSTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 275.56 Sell
20-day SMA: 293.91 Sell
50-day SMA: 323.85 Sell
200-day SMA: 235.89 Buy
8-day EMA: 276.42 Sell
20-day EMA: 291.61 Sell
50-day EMA: 311.36 Sell
200-day EMA: 251.41 Buy

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Strategy Earnings Growth & MSTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $37.64 per share, an increase this year of $2.96 per share, and an increase next year of $0.01 per share.

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Strategy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):